Arrowstreet Capital, Limited Partnership United Therapeutics Corp Transaction History

Arrowstreet Capital, Limited Partnership

$114 Billion
Q2 2024

A detailed history of Arrowstreet Capital, Limited Partnership transactions in United Therapeutics Corp stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 438,684 shares of UTHR stock, worth $176 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

438,684

Previous 97,949 347.87%

Holding current value

$176 Million

Previous $22.5 Million 521.05%

% of portfolio

0.12%

Previous 0.02%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$228.26 - $319.04 $77.8 Million - $109 Million	340,735 Added 347.87%	438,684 $140 Million
Q1 2024 May 15, 2024	BUY	$210.76 - $249.51 $18.5 Million - $21.9 Million	87,784 Added 863.59%	97,949 $22.5 Million
Q4 2023 Feb 14, 2024	SELL	$214.88 - $256.94 $7.02 Million - $8.4 Million	-32,681 Reduced 76.28%	10,165 $2.24 Million
Q3 2023 Nov 14, 2023	BUY	$211.82 - $248.24 $9.08 Million - $10.6 Million	42,846 New	42,846 $9.68 Million
Q4 2022 Feb 14, 2023	BUY	$205.95 - $280.43 $7.65 Million - $10.4 Million	37,158 Added 24.48%	188,974 $52.6 Million
Q3 2022 Nov 14, 2022	SELL	$203.3 - $244.17 $4.55 Million - $5.46 Million	-22,368 Reduced 12.84%	151,816 $31.8 Million
Q2 2022 Aug 15, 2022	BUY	$174.81 - $241.14 $29.6 Million - $40.8 Million	169,291 Added 3459.86%	174,184 $41 Million
Q1 2022 May 13, 2022	SELL	$166.16 - $213.96 $20.9 Million - $27 Million	-126,035 Reduced 96.26%	4,893 $878,000
Q4 2021 Feb 14, 2022	SELL	$184.32 - $216.08 $15.9 Million - $18.6 Million	-86,072 Reduced 39.66%	130,928 $28.3 Million
Q3 2021 Nov 12, 2021	BUY	$179.86 - $214.88 $17.5 Million - $20.9 Million	97,100 Added 80.98%	217,000 $40.1 Million
Q2 2021 Aug 13, 2021	BUY	$170.47 - $211.93 $20.4 Million - $25.4 Million	119,900 New	119,900 $21.5 Million
Q3 2020 Nov 12, 2020	SELL	$99.9 - $121.13 $2.43 Million - $2.94 Million	-24,290 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$92.74 - $125.82 $2.25 Million - $3.06 Million	24,290 New	24,290 $2.94 Million
Q1 2020 May 15, 2020	SELL	$79.39 - $115.35 $44 Million - $63.9 Million	-554,264 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$78.31 - $95.34 $8.82 Million - $10.7 Million	-112,568 Reduced 16.88%	554,264 $48.8 Million
Q3 2019 Nov 14, 2019	SELL	$74.85 - $85.99 $8.88 Million - $10.2 Million	-118,628 Reduced 15.1%	666,832 $53.2 Million
Q2 2019 Aug 14, 2019	BUY	$76.06 - $120.81 $35.5 Million - $56.4 Million	466,617 Added 146.35%	785,460 $61.3 Million
Q1 2019 May 15, 2019	BUY	$107.15 - $126.84 $31.7 Million - $37.5 Million	295,937 Added 1291.96%	318,843 $37.4 Million
Q4 2018 Feb 14, 2019	BUY	$101.4 - $128.73 $2.32 Million - $2.95 Million	22,906 New	22,906 $2.49 Million

Others Institutions Holding UTHR

# of Institutions

665

Shares Held

43M

Call Options Held

292K

Put Options Held

341K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $18.2B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.

Account

Arrowstreet Capital, Limited Partnership United Therapeutics Corp Transaction History